Nicotinamide riboside
- Generic Name
- Nicotinamide riboside
- Drug Type
- Small Molecule
- Chemical Formula
- C11H15N2O5
- CAS Number
- 1341-23-7
- Unique Ingredient Identifier
- 0I8H2M0L7N
- Background
Nicotinamide riboside is under investigation in clinical trial NCT03432871 (Nicotinamide Riboside and Mitochondrial Biogenesis).
Vitamin B3 Shows Promise in Reducing Lung Inflammation in COPD Patients
• A recent study reveals that daily intake of vitamin B3 significantly reduces lung inflammation in individuals with Chronic Obstructive Pulmonary Disease (COPD).
• The research demonstrated a notable decrease in interleukin 8 (IL-8), a key marker of inflammation, by 53% after six weeks and 63% after 18 weeks.
• Vitamin B3 treatment also increased levels of NAD, a chemical that declines with age and DNA damage, suggesting potential benefits against cellular aging.
• Researchers plan further studies to validate these findings and explore the long-term efficacy of nicotinamide riboside as a COPD treatment.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath